Saturday, July 11, 2026

Drug profile · INN

phenylephrine

phenylephrine (OMIDRIA) is a adrenergic receptor alpha-1 agonist.

EMA: approved Sensory organs (S01) S01
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — phenylephrine
Class
Sensory organs (S01)
Route
Patents
0
Programs
2
Data quality
0.83

Quick answer

phenylephrine (OMIDRIA) is a adrenergic receptor alpha-1 agonist.

Key facts

INN phenylephrine
Brand OMIDRIA
Mechanism Adrenergic receptor alpha-1 agonist
Therapeutic class Sensory organs (S01)
ATC code S01

Mechanism of action

Adrenergic receptor alpha-1 agonist

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. UP-CLI-2023-01 Phase 2 · Anaxis Pharma · to obtain pre-operative mydriasis or for diagnostic purposes
  2. Phenylephrine Approved · United Therapeutics Europe · Spinal Anesthesia

Related & competitor drugs

  1. aflibercept Sensory organs (S01)
  2. atropine sulfate Sensory organs (S01)
  3. bimatoprost Sensory organs (S01)
  4. atropine Sensory organs (S01)
  5. brinzolamide Sensory organs (S01)
  6. latanoprost Sensory organs (S01)

Frequently asked questions

What is phenylephrine?

phenylephrine (OMIDRIA) is a adrenergic receptor alpha-1 agonist.

What is the brand name for phenylephrine?

OMIDRIA is a marketed brand name for phenylephrine. Check FDA Drugs@FDA for the current US label holder and prescribing information.